Literature DB >> 21258356

Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent.

Zhi-fang Yang1, Ci-zhen Li, Wei Wang, Ying-min Chen, Ying Zhang, Yuan-mou Liu, Hong-wei Wang.   

Abstract

AIM: To examine the electrophysiological effects of sophocarpine on action potentials (AP) and ionic currents of cardiac myocytes and to compare some of these effects with those of amiodarone.
METHODS: Langendorff perfusion set-up was used in isolated guinea pig heart, and responses to sophocarpine were monitored using electrocardiograph. Conventional microelectrode, voltage clamp technique and perforated patch were employed to record fast response AP (fAP), slow response AP (sAP) and ionic currents in guinea pig papillary muscle or rabbit sinus node cells.
RESULTS: Tachyarrhythmia produced by isoprenaline (15 μmol/L) could be reversed by sophocarpine (300 μmol/L). Sophocarpine (10 μmol/L) decreased the amplitude by 4.0%, maximal depolarization velocity (V(max)) of the fAP by 24.4%, and Na(+) current (I(Na)) by 18.0%, while it prolonged the effective refractory period (ERP) by 21.1%. The same concentration of sophocarpine could also decrease the amplitude and V(max) of the sAP, by 26.8% and 25.7%, respectively, and attenuated the Ca(2+) current (I(CaL)) and the K(+) tail current substantially. Comparison of sophocarpine with amiodarone demonstrated that both prolonged the duration and the ERP of fAP and sAP, both decreased the amplitude and V(max) of the fAP and sAP, and both slowed the automatic heart rate.
CONCLUSION: Sophocarpine could reverse isoprenaline-induced arrhythmia and inhibit I(Na), I(CaL), and I(Kr) currents. The electrophysiological effects of sophocarpine are similar to those of amiodarone, which might be regarded as a prospective antiarrhythmic agent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258356      PMCID: PMC4002765          DOI: 10.1038/aps.2010.207

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  25 in total

1.  Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content.

Authors:  A Tosaki; S Balint; L Szekeres
Journal:  J Cardiovasc Pharmacol       Date:  1988-12       Impact factor: 3.105

2.  Protective effect of vagal stimulation on reperfusion arrhythmias in cats.

Authors:  G Zuanetti; G M De Ferrari; S G Priori; P J Schwartz
Journal:  Circ Res       Date:  1987-09       Impact factor: 17.367

3.  Effects of heart rate on extracellular [K+] accumulation during myocardial ischemia.

Authors:  J Weiss; K I Shine
Journal:  Am J Physiol       Date:  1986-06

4.  [Anti-arrhythmic effects of matrine].

Authors:  B H Zhang; N S Wang; X J Li; X J Kong; Y L Cai
Journal:  Zhongguo Yao Li Xue Bao       Date:  1990-05

Review 5.  Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.

Authors:  I Kodama; K Kamiya; J Toyama
Journal:  Am J Cardiol       Date:  1999-11-04       Impact factor: 2.778

6.  DMPO and reperfusion injury: arrhythmia, heart function, electron spin resonance, and nuclear magnetic resonance studies in isolated working guinea pig hearts.

Authors:  A Tosaki; P Braquet
Journal:  Am Heart J       Date:  1990-10       Impact factor: 4.749

7.  Isoproterenol and the genesis of reperfusion-induced arrhythmias in isolated rat heart: adrenoceptor or free radical-mediated mechanisms?

Authors:  A Tosaki; B Woodward; F Yamamoto; D J Hearse
Journal:  J Cardiovasc Pharmacol       Date:  1990-03       Impact factor: 3.105

8.  Voltage- and use-dependent modulation of calcium channel current in guinea pig ventricular cells by amiodarone and des-oxo-amiodarone.

Authors:  C Valenzuela; P B Bennett
Journal:  J Cardiovasc Pharmacol       Date:  1991-06       Impact factor: 3.105

9.  [Effects of chronic amiodarone therapy on L-type calcium current recovery and action potential duration of rabbit ventricular myocytes].

Authors:  Xiao-jing Zhao; Dong-lin Guo; Ying Wu; Teng-xian Liu; Gan-xin Yan
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2009-06

10.  Pacing and reperfusion induced arrhythmias: protection by slow heart rate in the rat heart.

Authors:  A Tosaki; S Balint; L Szekeres
Journal:  Cardiovasc Res       Date:  1988-11       Impact factor: 10.787

View more
  4 in total

1.  Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.

Authors:  Chen-He Zhou; Zhong-Li Shi; Jia-Hong Meng; Bin Hu; Chen-Chen Zhao; Yu-Te Yang; Wei Yu; Ze-Xin Chen; Boon Chin Heng; Virginia-Jeni Akila Parkman; Shuai Jiang; Han-Xiao Zhu; Hao-Bo Wu; Wei-Liang Shen; Shi-Gui Yan
Journal:  Br J Pharmacol       Date:  2018-02-14       Impact factor: 8.739

Review 2.  The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms.

Authors:  Jie Li; Dan Hu; Xiaoli Song; Tao Han; Yonghong Gao; Yanwei Xing
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

3.  New antiarrhythmic targets to control intracellular calcium handling.

Authors:  H E Driessen; V J A Bourgonje; T A B van Veen; M A Vos
Journal:  Neth Heart J       Date:  2014-05       Impact factor: 2.380

4.  Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice.

Authors:  Yin-Qiu Huang; Peng-Yan Li; Jia-Bo Wang; Hou-Qin Zhou; Zhi-Rui Yang; Rui-Chuang Yang; Zhao-Fang Bai; Li-Fu Wang; Jian-Yu Li; Hong-Hong Liu; Yan-Ling Zhao; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2016-08-12       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.